Hengrui Medicine (01276.HK) had repurchased a total of 13.7502 million shares by the end of July.

Zhuhong Finance APP news, Hengrui Medicine (01276.HK) announced that in July 2026, the company repurchased 280,000 shares through the centralized bidding trading method on the Shanghai Stock Exchange trading system. The repurchased shares account for 0.004% of the company's total share capital. The highest purchase price was RMB 54.05 per share, the lowest price was RMB 53.75 per share, and the total amount paid was RMB 15.0888 million (excluding transaction fees).